Cardiovascular diseases

Shimadzu - Deep insights for extended applications

In the year of Shimadzu’s 140th anniversary, new systems continue the company’s tradition in diagnostic imaging providing innovative technologies and industry firsts.

News • CARDIS

New European effort targeting mobile cardio vascular disease

Imec, Medtronic, Ghent University and their project partners today announced the launch of the CARDIS project. Together they will develop and validate an early-stage cardio vascular disease detection platform using integrated silicon photonics.

Stepping towards CD disease prevention

Cardiovascular disease develops in a slow and subclinical manner over decades, only to manifest suddenly and unexpectedly. Prevention is crucial, both before and after clinical appearance, Report: Dr Eduardo de la Sota

Article • Cardiac MRI

Cardiomyopathy: the chameleon disease

Cardiomyopathy is a disease with many faces, a 'chameleon', according to Professor Jeanette Schulz-Menger. MRI benefits and potential should be communicated better and to a wider clinical audience. Report: Axel Viola

CARDIOVIT MS-Line now with CCAA

In the year of its 40th anniversary, Schiller proudly presents an algorithm which immediately and accurately localises coronary occlusions and provides early detection of STEMI. This algorithm is now integrated in the sophisticated touch ECG devices, the Cardovit MS line.

The 12-lead mobile ECG

CardioSecur, a personalised mobile 12-lead ECG system with four electrodes for iPhone and iPad, enables patients to monitor their symptoms and transmit the data to their physicians in less than a minute.

Listen to your heart 24 hours a day

The ‘Fire of Life’ developed by Schiller is an intuitive visual presentation of frequency-domain heart rate variability (HRV) that makes the assessment of 24-hour results fast and simple.

Too many coronary stent procedures

In uncomplicated stable angina cases no evidence suggests that angioplasty reduces heart attacks or death risks, Mark Nicholls reports

Partnership optimises uniform processes

By recognition and early intervention against the most significant risk factors, many heart diseases can be prevented.

3D targeting of the heart

The heart is a structure in three dimensions and today we see it in three dimensions,’ Jose Luis Zamorano Gomez MD declared with satisfaction.

Hardly unnecessary blood tests

Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.

Disappointing HTN-3 trial results challenge future of procedure

It was the quiet before the storm. At the end of March, during the American College of Cardiology (ACC) meeting in Washington, the future of renal denervation was about to be decided with the presentation of the Medtronic-funded Simplicity HTN-3 clinical trial.

Pumping synchronously with the heart

Synchronised Cardiac Assist i-cor, which the company reports to be the first system that links mechanical circulatory support to the heartbeat.

First pacemaker with event-triggered IEGM transmissions

Biotronik, a leading manufacturer of cardiovascular medical technology, announced CE approval for its new Eluna pacemaker series. The new generation of pacemakers includes single and dual-chamber as well as cardiac resynchronization (CRT-P) devices.

Renal denervation on razor's edge ahead of trial results

It is the quiet before the storm. At the end of March, the future of renal denevation will be decided with the presentation of the Simplicity HTN-3 clinical trial at the American College of Cardiology meeting in Washington.

Promising substitutes for human hearts

Fully implantable mechanical hearts bring hope to 121,000 heart failure patients who will never receive a heart transplant

European approval for advanced SAPIEN 3 Valve

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced that it has received CE Mark in Europe and is initiating the launch of its most advanced transcatheter aortic valve, the Edwards SAPIEN 3 valve.

New AF classification by ECG will deliver personalised treatment

Despite the availability of cardioversion, ablation and medications to treat AF, outcomes are often poor because it is unclear which patients will benefit most. A new classification of atrial fibrillation (AF) by electrocardiogram (ECG) is set to be developed by European experts to aid personalised management of this devastating condition.